Title |
Opiates and elderly: Use and side effects
|
---|---|
Published in |
Clinical Interventions in Aging, June 2008
|
DOI | 10.2147/cia.s1847 |
Pubmed ID | |
Authors |
Diane L Chau, Vanessa Walker, Latha Pai, Lwin M Cho |
Abstract |
The evaluation of pain and the subsequent issue of pain control is a clinical challenge that all healthcare providers face. Pain in the elderly population is especially difficult given the myriad of physiological, pharmacological, and psychological aspects of caring for the geriatric patient. Opiates are the mainstay of pain treatment throughout all age groups but special attention must be paid to the efficacy and side effects of these powerful drugs when prescribing to a population with impaired metabolism, excretion and physical reserve. In a random chart review of 300 US veterans, 44% of those receiving an analgesic also received opioids. The increasing use of opiates for pain management by healthcare practitioners requires that those prescribing opioids be aware of the special considerations for treating the elderly. This article will address the precautions one must take when using opiates in the geriatric population, as well as the side effects and ways to minimize them. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 17% |
Kenya | 1 | 17% |
United Kingdom | 1 | 17% |
Unknown | 3 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 6 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Germany | 1 | <1% |
Unknown | 290 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 44 | 15% |
Student > Bachelor | 43 | 15% |
Student > Doctoral Student | 23 | 8% |
Student > Ph. D. Student | 20 | 7% |
Researcher | 19 | 7% |
Other | 51 | 18% |
Unknown | 91 | 31% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 98 | 34% |
Nursing and Health Professions | 25 | 9% |
Pharmacology, Toxicology and Pharmaceutical Science | 20 | 7% |
Biochemistry, Genetics and Molecular Biology | 9 | 3% |
Psychology | 9 | 3% |
Other | 31 | 11% |
Unknown | 99 | 34% |